T1	Pharmacological_substance 9 20	Methimazole
N1000 	Reference T1 MeSH:D008713	Methimazole
T2	Disorder 29 44	aplastic anemia
N1 	Reference T2 UMLS:C0002874	aplastic anemia
T7	Pharmacological_substance 179 196	antithyroid drugs
N1001 	Reference T7 MeSH:D013956	antithyroid drugs
T8	Disorder 214 229	aplastic anemia
N2 	Reference T8 UMLS:C0002874	aplastic anemia
T9	Disorder 231 233	AA
N3 	Reference T9 UMLS:C0002871	AA
T14	Disorder 406 421	agranulocytosis
N4 	Reference T14 UMLS:C0001824	agranulocytosis
T15	Disorder 543 558	Graves' disease
N5 	Reference T15 UMLS:C0018213	Graves' disease
T16	Pharmacological_substance 601 612	methimazole
N1002 	Reference T16 MeSH:D008713	methimazole
T21	Pharmacological_substance 705 742	granulocyte colony-stimulating factor
N1003 	Reference T21 MeSH:D016179	granulocyte colony-stimulating factor
T23	Pharmacological_substance 614 617	MMI
T4	Pharmacological_substance 108 145	granulocyte colony-stimulating factor
N1004 	Reference T4 MeSH:D016179	granulocyte colony-stimulating factor
T10	Pharmacological_substance 324 349	colony-stimulating factor
N1005 	Reference T10 MeSH:D003115	colony-stimulating factor
T11	Subject 511 537	58-year-old female patient
T12	Disorder 573 575	AA
N6 	Reference T12 UMLS:C0002871	AA
T19	Pharmacological_substance 744 749	G-CSF
N1006 	Reference T19 MeSH:D016179	G-CSF
N1007 	Reference T19 MeSH:D016179	G-CSF
T5	Pharmacological_substance 864 890	colony stimulating factors
N1008 	Reference T5 MeSH:D003115	colony stimulating factors
T17	Disorder 972 1001	hematologic adverse reactions
N7 	Reference T17 UMLS:C0559546	hematologic adverse reactions
T22	Pharmacological_substance 953 963	thionamide
N1009 	Reference T22 MeSH:C005896	thionamide
N1010 	Reference T22 MeSH:C009469	thionamide
N1011 	Reference T22 MeSH:C034609	thionamide
T26	Subject 102 107	human
T27	Subject 699 704	human
T28	Pharmacological_substance 638 641	MMI
T31	Subject 306 311	human
T32	Subject 383 391	patients
T33	Disorder 484 486	AA
N8 	Reference T33 UMLS:C0002871	AA
T35	Speculation_cue 447 457	some doubt
